Ausgabe 4/2016
Inhalt (9 Artikel)
- Acute Lymphocytic Leukemias (K Ballen, Section Editor)
Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia
Ajoy Dias, Saad J. Kenderian, Gustavo F. Westin, Mark R. Litzow
- Health Economics (N Khera, Section Editor)
Scientific Achievements May Not Reach Everyone: Understanding Disparities in Acute Leukemia
Manali I. Patel
- Health Economics (N Khera, Section Editor)
Exploring Big Data in Hematological Malignancies: Challenges and Opportunities
Gustavo F. Westin, Ajoy L. Dias, Ronald S. Go
- Health Economics (N Khera, Section Editor)
Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant
Anna Barata, William A. Wood, Sung Won Choi, Heather S. L. Jim
- Health Economics (N Khera, Section Editor)
Oral Chemotherapy in Patients with Hematological Malignancies—Care Process, Pharmacoeconomic and Policy Implications
Jeffrey Betcher, Elizabeth Dow, Nandita Khera
- Health Economics (N Khera, Section Editor)
Bending the Cost Curve in Childhood Cancer
Heidi Russell, M. Brooke Bernhardt
- Health Economics (N Khera, Section Editor)
Value Based Care and Patient-Centered Care: Divergent or Complementary?
Eric K. Tseng, Lisa K. Hicks
- CART and Immunotherapy (M Ruella, Section Editor)
T-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies
Nasheed M. Hossain, Aude G. Chapuis, Roland B. Walter
- CART and Immunotherapy (M Ruella, Section Editor)
Planes, Trains, and Automobiles: Perspectives on CAR T Cells and Other Cellular Therapies for Hematologic Malignancies
Saar Gill